GR851774B - - Google Patents

Info

Publication number
GR851774B
GR851774B GR851774A GR850101774A GR851774B GR 851774 B GR851774 B GR 851774B GR 851774 A GR851774 A GR 851774A GR 850101774 A GR850101774 A GR 850101774A GR 851774 B GR851774 B GR 851774B
Authority
GR
Greece
Prior art keywords
radical
alkyloxy
alkyl
het
optionally substituted
Prior art date
Application number
GR851774A
Other languages
English (en)
Inventor
Cotrel Claude
Gyon Claude
Roussel Gerard
Taurand Gerard
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of GR851774B publication Critical patent/GR851774B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
GR851774A 1984-07-19 1985-07-17 GR851774B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8411442A FR2567887B1 (fr) 1984-07-19 1984-07-19 Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
GR851774B true GR851774B (el) 1985-11-26

Family

ID=9306273

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851774A GR851774B (el) 1984-07-19 1985-07-17

Country Status (27)

Country Link
US (1) US4642308A (el)
EP (1) EP0172083B1 (el)
JP (1) JPS6163656A (el)
KR (1) KR860001100A (el)
AT (1) ATE33652T1 (el)
AU (1) AU572672B2 (el)
CA (1) CA1224787A (el)
CS (1) CS253730B2 (el)
DD (1) DD240011A5 (el)
DE (1) DE3562250D1 (el)
DK (1) DK327285A (el)
ES (1) ES8604584A1 (el)
FI (1) FI79313C (el)
FR (1) FR2567887B1 (el)
GR (1) GR851774B (el)
HU (1) HU199802B (el)
IL (1) IL75817A (el)
MA (1) MA20487A1 (el)
NO (1) NO161673C (el)
NZ (1) NZ212764A (el)
OA (1) OA08069A (el)
PH (1) PH21301A (el)
PL (1) PL145331B1 (el)
PT (1) PT80840B (el)
SU (1) SU1417797A3 (el)
YU (1) YU118785A (el)
ZA (1) ZA855409B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208621B1 (fr) * 1985-07-11 1989-04-12 Rhone-Poulenc Sante Amides substitués, leur préparation et compositions qui les contiennent
FR2592882B2 (fr) * 1986-01-16 1988-03-11 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
US4753941A (en) * 1986-01-16 1988-06-28 Rhone-Poulenc Sante Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics
US5197518A (en) * 1991-06-27 1993-03-30 Double Containment Systems Centering support assembly for double containment pipe systems
GB9711257D0 (en) 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
US6340690B1 (en) * 1999-02-22 2002-01-22 Bio-Chem Pharma Inc. Antiviral methods using [1,8]naphthyridine derivatives
US7432281B2 (en) 2003-10-07 2008-10-07 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US20080300243A1 (en) * 2005-02-28 2008-12-04 Kelly Michael G Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2013090725A1 (en) * 2011-12-15 2013-06-20 Philadelphia Health & Education Corporation NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF
CN105646487B (zh) * 2016-03-15 2017-12-05 红河学院 一类溴代1,8‑萘啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1006725A (fr) * 1948-08-31 1952-04-28 Cilag Spa Nouveaux dérivés de la naphtyridine et procédé pour leur préparation
GB661515A (en) * 1948-08-31 1951-11-21 Cilag Ltd Process for the production of naphthyridine derivatives
US3389142A (en) * 1966-09-29 1968-06-18 Bristol Myers Co Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids
US3576809A (en) * 1968-05-06 1971-04-27 Miles Lab 2-substituted derivatives of 6-methoxyquinoline
US3624097A (en) * 1969-07-22 1971-11-30 Warner Lambert Co N-pyridine 5-aminooxazoles
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use

Also Published As

Publication number Publication date
HU199802B (en) 1990-03-28
ES8604584A1 (es) 1986-02-01
DK327285A (da) 1986-01-20
CA1224787A (fr) 1987-07-28
FI79313C (fi) 1989-12-11
IL75817A0 (en) 1985-11-29
FR2567887B1 (fr) 1986-12-19
IL75817A (en) 1988-06-30
PL254570A1 (en) 1986-10-21
ATE33652T1 (de) 1988-05-15
SU1417797A3 (ru) 1988-08-15
FI852821L (fi) 1986-01-20
OA08069A (fr) 1987-03-31
JPS6163656A (ja) 1986-04-01
EP0172083B1 (fr) 1988-04-20
HUT40799A (en) 1987-02-27
DK327285D0 (da) 1985-07-18
NZ212764A (en) 1988-05-30
PL145331B1 (en) 1988-09-30
DD240011A5 (de) 1986-10-15
AU572672B2 (en) 1988-05-12
KR860001100A (ko) 1986-02-22
AU4509085A (en) 1986-01-23
NO852877L (no) 1986-01-20
MA20487A1 (fr) 1986-04-01
PT80840B (pt) 1988-02-17
US4642308A (en) 1987-02-10
FI852821A0 (fi) 1985-07-18
CS253730B2 (en) 1987-12-17
PT80840A (fr) 1985-08-01
ZA855409B (en) 1986-04-30
NO161673C (no) 1989-09-13
FR2567887A1 (fr) 1986-01-24
EP0172083A1 (fr) 1986-02-19
YU118785A (en) 1988-10-31
ES545336A0 (es) 1986-02-01
PH21301A (en) 1987-09-28
NO161673B (no) 1989-06-05
DE3562250D1 (en) 1988-05-26
FI79313B (fi) 1989-08-31

Similar Documents

Publication Publication Date Title
DE3562250D1 (en) Substituted amides, their preparation and pharmaceutical compositions containing them
HUT58760A (en) Process for produicng compounds of fibrinogene-receptor antagonistic activity and pharmaceutical compositions containing them
ES8601900A1 (es) Un procedimiento para la preparacion de un derivado de pirazol
MD960282A (en) Herbicidal heterocyclic-substituted pyridines
EP0422456A3 (en) Pyridine derivatives and their use in combating unwanted plant growth
NZ221314A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition
ZA845622B (en) Pyridylalkylamino pyrimidone derivatives
AU589484B2 (en) New substituted amides, their preparation and pharmaceutical compositions which contain them
IL93949A0 (en) Thioformamide derivatives and pharmaceutical compositions containing them
IL72817A (en) 3-and/or 6-(3-(2-haloethyl)-3-nitrosoureido)-sugars,their preparation and pharmaceutical compositions containing them
DE3762859D1 (de) Substituierte amide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
HU00224A9 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
IL97715A0 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same